Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (91-100 of 194) with videos related to

Pageof 20
Sort By:
Chest|February 11, 2021
Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic PolyangiitisHironao Hozumi, Masato Kono, Hirotsugu Hasegawa, et al.
The Journal of Infection|August 4, 2019
Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung diseaseDaisuke Akahori, Yuzo Suzuki, Koushi Yokomura, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung CancerKazuo Tsuchiya, Masato Karayama, Taichi Sato, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 24, 2024
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twinsKazuo Tsuchiya, Yutaro Nakamura, Yasuhiro Setoguchi, et al.
Respiratory Investigation|June 22, 2021
Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosisKazuki Tanaka, Noriyuki Enomoto, Hironao Hozumi, et al.
Respirology (Carlton, Vic.)|September 24, 2020
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapyYuzo Suzuki, Yuya Aono, Masato Kono, et al.
Scientific Reports|December 15, 2025
Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort studyKeisuke Morikawa, Yuzo Suzuki, Shinpei Kato, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2016
Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancerMasato Karayama, Naoki Inui, Tomoyuki Fujisawa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 24, 2020
Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancerMasato Karayama, Nobuko Yoshizawa, Masataka Sugiyama, et al.
Autophagy|January 31, 2022
Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthmaYuzo Suzuki, Yuya Aono, Norimichi Akiyama, et al.
Pageof 20

Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Chest|February 11, 2021
Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic PolyangiitisHironao Hozumi, Masato Kono, Hirotsugu Hasegawa, et al.
The Journal of Infection|August 4, 2019
Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung diseaseDaisuke Akahori, Yuzo Suzuki, Koushi Yokomura, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung CancerKazuo Tsuchiya, Masato Karayama, Taichi Sato, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 24, 2024
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twinsKazuo Tsuchiya, Yutaro Nakamura, Yasuhiro Setoguchi, et al.
Respiratory Investigation|June 22, 2021
Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosisKazuki Tanaka, Noriyuki Enomoto, Hironao Hozumi, et al.
Respirology (Carlton, Vic.)|September 24, 2020
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapyYuzo Suzuki, Yuya Aono, Masato Kono, et al.
Scientific Reports|December 15, 2025
Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort studyKeisuke Morikawa, Yuzo Suzuki, Shinpei Kato, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2016
Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancerMasato Karayama, Naoki Inui, Tomoyuki Fujisawa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 24, 2020
Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancerMasato Karayama, Nobuko Yoshizawa, Masataka Sugiyama, et al.
Autophagy|January 31, 2022
Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthmaYuzo Suzuki, Yuya Aono, Norimichi Akiyama, et al.
Pageof 20